Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

Scientists decode key mutation in many cancers

Scientists decode key mutation in many cancers

Survival gap eliminated for Black cord blood recipients with blood cancers, study finds

Survival gap eliminated for Black cord blood recipients with blood cancers, study finds

Described the epigenetic hallmarks that define cancer

Described the epigenetic hallmarks that define cancer

CAR-T safe and effective on an outpatient basis in community hospitals

CAR-T safe and effective on an outpatient basis in community hospitals

Radon, even at levels below EPA guideline for mitigation, is linked to childhood leukemia

Radon, even at levels below EPA guideline for mitigation, is linked to childhood leukemia

Unexpected immune response may hold key to long-term cancer remission

Unexpected immune response may hold key to long-term cancer remission

FDA approves isatuximab-irfc with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma

FDA approves isatuximab-irfc with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma

SWOG S1712 supports adding ruxolitinib to TKIs for chronic myeloid leukaemia

SWOG S1712 supports adding ruxolitinib to TKIs for chronic myeloid leukaemia

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain paediatric leukaemia subtypes

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain paediatric leukaemia...

More from ecancer